VanEck Associates’s AMN Healthcare AMN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-8,820
Closed -$751K 1395
2023
Q3
$751K Buy
8,820
+2,644
+43% +$251K ﹤0.01% 965
2023
Q2
$674K Buy
6,176
+97
+2% +$9.2K ﹤0.01% 963
2023
Q1
$504K Buy
6,079
+4,494
+284% +$423K ﹤0.01% 1007
2022
Q4
$163K Buy
1,585
+202
+15% +$23.3K ﹤0.01% 1150
2022
Q3
$147K Buy
1,383
+125
+10% +$13.7K ﹤0.01% 1101
2022
Q2
$138K Buy
+1,258
New +$125K ﹤0.01% 1150

Other funds holding AMN

VanEck Associates's AMN Position: Q4 2023 in Review

VanEck Associates sold out of AMN Healthcare (AMN) in Q4 2023, closing a stake of 8,820 shares — an estimated $751K sold.

VanEck Associates first reported a position in AMN in Q2 2022 and held it in 6 quarters. The position peaked at $751K in Q3 2023. 381 funds tracked by Wall St. Rank hold AMN as of Q4 2023.

  • VanEck Associates reported no remaining AMN Healthcare position as of Q4 2023 after selling out during the quarter.
  • VanEck Associates sold 8,820 AMN Healthcare shares in Q4 2023, an estimated $751K.
  • VanEck Associates first reported a position in AMN Healthcare in Q2 2022 and held it in 6 quarters.
  • VanEck Associates's AMN Healthcare position peaked at $751K in Q3 2023.
  • 381 funds tracked by Wall St. Rank held AMN Healthcare as of Q4 2023.

Based on VanEck Associates's 13F filing for Q4 2023, filed 5 Feb 2024.